News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
New 2025-2027 committee nominations are now open – IASLC
IASLC/X
Feb 10, 2025, 18:17

New 2025-2027 committee nominations are now open – IASLC

International Association for the Study of Lung Cancer shared a post on X:

“Calling all IASLC members! Your voice matters in shaping the future of thoracic cancer care. Nominate yourself or a colleague for an IASLC committee and help drive innovation in research and patient care.

Apply now.”

More posts featuring IASLC.

cancer committee nominations IASLC International Association for the Study of Lung Cancer OncoDaily Oncology
Special Coverage
Blog
Feb 10, 2025, 18:17
New 2025-2027 committee nominations are now open - IASLC
Blog
Feb 10, 2025, 18:10
Rasu Shrestha: Proud of what we, as a team across Advocate Health, have already accomplished
Blog
Feb 10, 2025, 17:17
Nelson Dusetti on personalized chemotherapy for pancreatic cancer at Jeudi du PSCC
Blog
Feb 10, 2025, 16:55
Did you know that some cancer treatments cause cardiotoxicity? - Oncogene Cancer Research
Blog
Feb 10, 2025, 16:49
AAMC Statement on Drastic Cuts to NIH-Funded Research
Science
Feb 10, 2025, 16:45
Patrick Hwu: The potential of personalized cancer vaccines as an effective adjuvant therapy in RCC
Insight
Feb 10, 2025, 16:08
Drew Moghanaki: A common-sense interpretation of clinical trial data
Blog
Feb 10, 2025, 15:56
Herbert Loong: Join us for the inaugural ESMO TAT Asia 2025 meeting
Blog
Feb 10, 2025, 15:44
Monica Bertagnolli: At times of systemic stress, it is the next generations who stand to lose the most
Blog
Feb 10, 2025, 15:43
Bruna Pellini: Honored to be featured in the 2025 Moffitt Women in Oncology issue
Blog
Feb 10, 2025, 15:38
Wafik S. El-Deiry: Science is not a business
Science
Feb 10, 2025, 15:34
Angela Mastronuzzi: Cancer risk in carriers of TP53 germline variants